Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Just Ingredients NAD+ Complex Features Compound Solutions' Newly Patented NAD3®


News provided by

Compound Solutions, Inc.

Oct 15, 2026, 14:55 ET

Share this article

Share toX

Share this article

Share toX

The daily longevity capsule pairs NAD3® with nicotinamide riboside and organic resveratrol, anchoring the formula in mitochondrial function rather than NAD+ levels alone.

CARLSBAD, Calif., Oct. 15, 2026 /PRNewswire-PRWeb/ -- Compound Solutions, Inc. (CSI), a leading ingredient house supplying science-backed nutraceutical ingredients, today announced that its newly patented ingredient NAD3® is featured in Just Ingredients NAD+ Complex, a daily capsule built for healthy aging and cellular energy.

Just Ingredients has built a loyal following on transparent labels and formulas developed alongside doctors and other experts, with third-party testing done at the ingredient source. NAD+ Complex is the brand's entry into the longevity space. NAD3® sits alongside nicotinamide riboside, a form of vitamin B3 the body converts into NAD+, with organic resveratrol and organic beet root rounding out the formula.

The NAD+ category has largely organized itself around one goal - pushing NAD+ levels higher. But the research keeps returning to a different measure - the ratio of NAD+ to NADH - the ratio that tracks how efficiently mitochondria convert food into usable energy, which is arguably the most important measure of healthy aging. The NAD+/NADH ratio says more about the root of our cellular health than a total NAD+ count does.

Mitochondrial function sits close to the center of healthy aging. The need for energy touches every system in the body, and the efficiency of that process tends to decline over time. Supporting it is one of the more direct ways to support healthy aging, which is why mitochondrial performance and NAD3® have become such a focal point for longevity formulators.

NAD3®'s role in the Just Ingredients formula is energy, cellular health and mitochondrial support, and Compound Solutions built the ingredient for exactly that. Human research on NAD3® supports a healthy NAD+ to NADH ratio, the balance that shapes how efficiently cells turn food into energy. That same research supports cardiovascular health, which gives NAD3® two physiological benefits inside one ingredient.

"Healthy aging isn't about chasing the newest trend. It's about giving your body what it needs to keep doing what it does best. We spent a long time on this formula because we wanted every ingredient to earn its place, and NAD3® checked every box for us," said Karalynne Call, Founder & CEO of Just Ingredients.

"Just Ingredients has built an incredibly strong trust with its consumers. That trust is earned over many, many years, and we've loved the opportunity to support Just Ingredients with ingredients like NAD3® that their consumers trust, value and rely on for optimal health," said Matt Titlow, CEO of Compound Solutions.

Just Ingredients NAD+ Complex is available now at justingredients.com and at Target. The collaboration between Just Ingredients and Compound Solutions reflects CSI's ongoing mission to partner with forward-thinking brands and bring differentiated, science-backed products to market that meet the evolving needs of today's longevity consumer.

What is NAD3®?

NAD3® is a patented longevity complex from Compound Solutions built on wasabi powder, theacrine and copper nicotinate. Human research supports NAD3® for maintaining a healthy NAD+ to NADH ratio, the balance that reflects how efficiently mitochondria convert food into cellular energy, and for supporting cardiovascular health.

About Compound Solutions, Inc.

Compound Solutions (CSI) is one of the most innovative, trusted and credible ingredient houses in the dietary supplement industry. Since 1998, CSI has been the go-to company for science-backed ingredients that lead the way in wellness, gut health, sports nutrition and beyond. CSI's long-lasting relationships with global customers and suppliers have earned it a reputation for collaboration and community. For more information, visitCompoundSolutions.com, and follow Compound Solutions onLinkedIn andInstagram.

Media Contact

Ryan Harris, Compound Solutions, Inc., 1 7607399886, [email protected], https://compoundsolutions.com/

SOURCE Compound Solutions, Inc.

Modal title

Just Ingredients NAD+ Complex, the daily longevity formula featuring patented NAD3® from Compound Solutions.
Just Ingredients NAD+ Complex, the daily longevity formula featuring patented NAD3® from Compound Solutions.
Just Ingredients NAD+ Complex, the daily longevity formula featuring patented NAD3® from Compound Solutions.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.